[
    [
        {
            "time": "",
            "original_text": "多家公司发布增持公告：山东威达等获力捧",
            "features": {
                "keywords": [
                    "增持",
                    "山东威达"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "多家公司发布增持公告：山东威达等获力捧",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "医药生物行业周报：板块持续回调 关注分销企业Q2业绩改善",
            "features": {
                "keywords": [
                    "医药生物",
                    "回调",
                    "分销企业",
                    "Q2业绩改善"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "医药生物行业周报：板块持续回调 关注分销企业Q2业绩改善",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 6,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "[推荐评级]医药行业周报：市场震荡调整 看好优质标的可持续成长性",
            "features": {
                "keywords": [
                    "医药",
                    "震荡调整",
                    "优质标的",
                    "成长性"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[推荐评级]医药行业周报：市场震荡调整 看好优质标的可持续成长性",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "[强于大市评级]医药行业周报：医药指数波动 不改2018年医药牛市",
            "features": {
                "keywords": [
                    "医药",
                    "指数波动",
                    "牛市"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "[强于大市评级]医药行业周报：医药指数波动 不改2018年医药牛市",
                "Correlation": 8,
                "Sentiment": 9,
                "Importance": 8,
                "Impact": 8,
                "Duration": 9,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "original_text": "医药行业2018年6月投资策略：结构分化，重视前期滞涨个股",
            "features": {
                "keywords": [
                    "医药",
                    "投资策略",
                    "结构分化",
                    "滞涨个股"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "医药行业2018年6月投资策略：结构分化，重视前期滞涨个股",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 4
            }
        },
        {
            "time": "",
            "original_text": "【医药*全铭团队】医保局成立点评：三保合一提升医保基金运行效率，定价、采购、支付三合一加强医改执行力",
            "features": {
                "keywords": [
                    "医保局",
                    "三保合一",
                    "医保基金",
                    "定价",
                    "采购",
                    "支付",
                    "医改"
                ],
                "sentiment_score": 0.85,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "【医药*全铭团队】医保局成立点评：三保合一提升医保基金运行效率，定价、采购、支付三合一加强医改执行力",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 10,
                "Impact": 9,
                "Duration": 10,
                "Entity_Density": 7,
                "Market_Scope": 10,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]